Literature DB >> 18376056

A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer's Abeta using yeast.

Prashant Bharadwaj1, Lynne Waddington, Jose Varghese, Ian G Macreadie.   

Abstract

The 42 amino acid amyloid-beta (Abeta) can exist in multiple physical states including oligomers and fibrils. This study shows that fibril formation is hastened by the biological buffers required to support the growth of mammalian cells, but is prevented if Abeta is maintained in water. Here we describe a method to produce Abeta in oligomeric form and the comparison of stable fibrillar and non-fibrillar forms in cell toxicity studies in water, achieved through the use of yeast. We show that extracellular, non-fibrillar Abeta causes a dose dependent loss of cell viability while fibrillar Abeta has low toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376056     DOI: 10.3233/jad-2008-13204

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

Review 1.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

2.  Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast.

Authors:  Afsaneh Porzoor; Joanne M Caine; Ian G Macreadie
Journal:  Prion       Date:  2014       Impact factor: 3.931

3.  Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast.

Authors:  Prashant R Bharadwaj; Giuseppe Verdile; Renae K Barr; Veer Gupta; John W Steele; M Lenard Lachenmayer; Zhenyu Yue; Michelle E Ehrlich; Gregory Petsko; Shulin Ju; Dagmar Ringe; Sonia E Sankovich; Joanne M Caine; Ian G Macreadie; Sam Gandy; Ralph N Martins
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  TorsinA and the torsinA-interacting protein printor have no impact on endoplasmic reticulum stress or protein trafficking in yeast.

Authors:  Julie S Valastyan; Susan Lindquist
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

Review 5.  Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Authors:  Prashant R Bharadwaj; Ashok K Dubey; Colin L Masters; Ralph N Martins; Ian G Macreadie
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

6.  Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs.

Authors:  Sei-Kyoung Park; Kiira Ratia; Mariam Ba; Maria Valencik; Susan W Liebman
Journal:  Microb Cell       Date:  2016-01-20

Review 7.  Recent Insights on Alzheimer's Disease Originating from Yeast Models.

Authors:  David Seynnaeve; Mara Del Vecchio; Gernot Fruhmann; Joke Verelst; Melody Cools; Jimmy Beckers; Daniel P Mulvihill; Joris Winderickx; Vanessa Franssens
Journal:  Int J Mol Sci       Date:  2018-07-03       Impact factor: 5.923

Review 8.  Contribution of yeast models to neurodegeneration research.

Authors:  Clara Pereira; Cláudia Bessa; Joana Soares; Mariana Leão; Lucília Saraiva
Journal:  J Biomed Biotechnol       Date:  2012-07-15

9.  Development of Convenient System for Detecting Yeast Cell Stress, Including That of Amyloid Beta.

Authors:  Yen Nhi Luu; Ian Macreadie
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.